Arrowhead Pharmaceuticals: Q2 Earnings Insights

Arrowhead Pharmaceuticals ARWR reported its Q2 earnings results on Tuesday, May 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Arrowhead Pharmaceuticals beat estimated earnings by 612.5%, reporting an EPS of $0.41 versus an estimate of $-0.08.

Revenue was up $118.99 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 6.92% drop in the share price the next day.

Here's a look at Arrowhead Pharmaceuticals's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.45 -0.10 -0.20 -0.13
EPS Actual -0.60 -0.61 -0.29 -0.26
Revenue Estimate 51.04M 56.77M 37.52M 37.70M
Revenue Actual 27.44M 38.28M 45.89M 32.81M

To track all earnings releases for Arrowhead Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!